6 hours Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily
Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.
The post Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? appeared first on Investor's Business …
Business · Eli Lilly (LLY) · ResMed (RMD)
X